With the U.S. Within Months of the First Covid-19 Vaccine Approval, What’s Next?
By Amit Kumar, Ph.D., CEO of Anixa Biosciences
Latest News & Events
Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy
Read More...Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic
Read More...Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million
Read More...